Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Philippe Broët

Genomic Aberrations Associated With Outcome in Anaplastic Oligodendroglial Tumors Treated Within the EORTC Phase III Trial 26951

Journal of Neuro-Oncology

English

Two-Sample Statistics for Testing the Equality of Survival Functions Against Improper Semi-Parametric Accelerated Failure Time Alternatives: An Application to the Analysis of a Breast Cancer Clinical Trial

Lifetime Data Analysis

Medicine

Applied Mathematics

2004

English

Related publications

Outcome of Children and Adolescents With Lymphoblastic Lymphoma Treated With the Eortc 58951 Protocol

Hematological Oncology

English

The EORTC Module for Quality of Life in Patients With Thyroid Cancer: Phase III

Endocrine-Related Cancer

English

Gene Expression in Oligodendroglial Tumors

English

Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation Alone in Resected Stage III Melanoma: Final Results of EORTC 18991, a Randomised Phase III Trial

The Lancet

Medicine

2008

English

Long-Term Analysis of the NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide.

Journal of Clinical Oncology

English

Outcome of Infants and Young Children With Newly Diagnosed Ependymoma Treated on the “Head Start” III Prospective Clinical Trial

Journal of Neuro-Oncology

English

Common Chromosomal Aberrations Detected by Array Comparative Genomic Hybridization in Specialized Stromal Tumors of the Prostate

English

Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

Journal of Clinical Oncology

English

A Phase II Study of Paclitaxel in Advanced Bronchioloalveolar Carcinoma (EORTC Trial 08956)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Philippe Broët

Genomic Aberrations Associated With Outcome in Anaplastic Oligodendroglial Tumors Treated Within the EORTC Phase III Trial 26951

Two-Sample Statistics for Testing the Equality of Survival Functions Against Improper Semi-Parametric Accelerated Failure Time Alternatives: An Application to the Analysis of a Breast Cancer Clinical Trial

Related publications

Outcome of Children and Adolescents With Lymphoblastic Lymphoma Treated With the Eortc 58951 Protocol

The EORTC Module for Quality of Life in Patients With Thyroid Cancer: Phase III

Gene Expression in Oligodendroglial Tumors

Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation Alone in Resected Stage III Melanoma: Final Results of EORTC 18991, a Randomised Phase III Trial

Long-Term Analysis of the NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide.

Outcome of Infants and Young Children With Newly Diagnosed Ependymoma Treated on the “Head Start” III Prospective Clinical Trial

Common Chromosomal Aberrations Detected by Array Comparative Genomic Hybridization in Specialized Stromal Tumors of the Prostate

Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

A Phase II Study of Paclitaxel in Advanced Bronchioloalveolar Carcinoma (EORTC Trial 08956)